Profile
ZJYL ISRG BDXA BDX RMD ALC
Company Name Jin Medical International Ltd. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $91.74M $167.60B $55.91B $54.60B $40.88B $38.72B
Employees 0.27K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Erqi Wang Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
ZJYL ISRG BDXA BDX RMD ALC
Quant Rating Score 3 3 5 3 4 3
Quant Rating Neutral Neutral Strong Buy Neutral Buy Neutral
Trading
ZJYL ISRG BDXA BDX RMD ALC
Last Close $0.586 $433.66 $59.24 $187.57 $271.71 $77.2
High 52 $4.08 $610.45 $59.24 $249.08 $293.73 $100.07
Low 52 $0.57 $433.48 $59.24 $165.15 $204.58 $77.2
Price vs. 52 Week High -85.64 % -28.96 % 0 % -24.69 % -7.5 % -22.85 %
Price vs. 52 Week Low 2.81 % 0.04 % 0 % 13.58 % 32.81 % 0 %
Total Return
ZJYL ISRG BDXA BDX RMD ALC
1 Month Return -3.89 % -9.86 % 0 % -3.81 % -5.04 % -12.4 %
3 Month Return -16.76 % -14.88 % 0 % 11.26 % 8.3 % -8.93 %
6 Month Return -34.16 % -10.35 % 0 % -19.19 % 23.45 % -15.08 %
9 Month Return -26.75 % -17.63 % 0 % -16.3 % 18.03 % -8.9 %
YTD Return -24.7 % -16.92 % 0 % -17.32 % 18.81 % -9.06 %
1 Year Return -77.11 % -10.05 % 0 % -19.01 % 14.15 % -20.12 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ZJYL ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.22 % 2.18 % 0.78 % 0.43 %
Dividend Paid and Capex Coverage Ration (TTM) -11.95 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Growth
ZJYL ISRG BDXA BDX RMD ALC
Asset Growth 39.2 % 8.54 % 2.48 %
Gross Profit Growth 40.06 % 11.69 % 5.05 %
Revenue Growth 18.57 % 4.16 % 4.82 %
Revenue 3 Year 93.55 % 5.3 % 18.48 %
Revenue 5 Year 195.07 % 8.72 % 30.35 %
Revenue 10 Year 187.3 % 59.37 % 50.3 %
EBIT Growth 26.91 % 19.82 % 41.82 %
Net Income Growth 27.71 % 14.89 % 4.52 %
Net Income 3 Yeari Growth Per Share 138.85 % -18.63 % 168.34 %
Net Income 5 Yeari Growth Per Share 157.7 % 28.82 % 253.24 %
Net Income 10 Yeari Growth Per Share 155.24 % -4.02 % 239.64 %
Operating Income Growth 26.91 % 13.55 % 36 %
Operating Cash Flow Growth (CFG) -138.87 % 27.07 % 49.64 %
Operating 3 Year CFG -135.33 % -18.4 % 53.05 %
Operating 5 Year CFG -132.91 % 6.25 % 122.93 %
Operating 10 Year CFG -28.91 % 45.28 % 55.79 %
EPS Growth 18.69 % 18.31 % 4.04 %
EPS Diluted Growth 18.69 % 18.62 % 4.59 %
Book Value Per Share 10.44 % -0.85 % 4.21 %
Share Holder 3 Year Equity Growth Per Share 251.23 % 9.16 % 10.93 %
Share Holder 5 Year Equity Growth Per Share 588.28 % 14.4 % 10.26 %
Share Holder 10 Year Equity Growth Per Share 718.35 % 241.78 % -9.87 %
Dividend Per Share Growth - -2.44 % 11.75 %
Dividend 3 Year Growth Per Share - 4.79 % 138.09 %
Dividend 5 Year Growth Per Share - 4.14 % -
Dividend 10 Year Growth Per Share - 74.3 % -
Debt Growth 182.12 % 31.74 % 0.02 %
Free Cash Flow Growth -177.91 % 45.25 % 162.01 %
Updated On 30 Sep 2024 30 Sep 2024 31 Dec 2024
Profitability
ZJYL ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 42.31 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM 6.07 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM 9.94 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 10.56 % 14.26 % 5.78 % 5.78 % 23.58 % 4.98 %
Net Income Per EBT TTM 87.47 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 105.06 % 113.2 % 70.86 % 70.86 % 99.42 % 86.96 %
EBIT Per Revenue TTM 16.59 % 28.8 % 12.63 % 12.63 % 32.79 % 14.38 %
Cash Flow To Debt Ratio TTM -10.62 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 2.08 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 3.49 11.43 1.85 1.85 7.52 5.03
Inventory Turnover TTM 1.48 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 1061.73 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 39.79 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -0.01 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -0.01 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 17.09 % 1485.77 % 262.85 % 262.85 % 834.65 % 284.33 %
Operating Cash Flow Sales Ratio TTM -6.76 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 108.37 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM -10.62 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -68.7 84.04 21.08 21.41 24.64 24.23
Price To Operating Cash Flows Ratio TTM -74.45 59.31 16.6 16.86 23.35 18.8
Price Cash Flow Ratio TTM -74.45 59.31 16.6 16.86 23.35 18.8
Income Statement (TTM)
ZJYL ISRG BDXA BDX RMD ALC
Revenue $0.02B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $0.01B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 40.43% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $0B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $0B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted 0.02 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
ZJYL ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0.02B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $0.03B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0.02B $7.05B $0.45B $0.45B $0.1B $0.91B
Total Debt $0.01B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0.05B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
ZJYL ISRG BDXA BDX RMD ALC
Net Income $0B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $-0B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 77.79
ANGO AngioDynamics, Inc. 11
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 134.46
ATRC AtriCure, Inc. 36.68
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 31.04
BAX Baxter International Inc. 23.7
BDX Becton, Dickinson and Company 188.38
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.385
BLFS BioLife Solutions, Inc. 26.26
COO The Cooper Companies, Inc. 67.22
DXR Daxor Corporation 11.41
EKSO Ekso Bionics Holdings, Inc. 4.28
FEMY Femasys Inc. 0.3591
ETFs With Exposure to ZJYL
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0 54.27
VT Vanguard Total World Stock Index Fund 0 137.76
VXUS Vanguard Total Intl Stock Idx Fund 0 73.725
VSS Vanguard FTSE All-World ex-US Small Capital Index Fund 0 143.87
PGJ Invesco Golden Dragon China ETF 0.061 33.87
VSGX Vanguard ESG International Stock ETF 0 69.94
VTSNX Vanguard Total Intl Stock Idx Fund 0 157.95
VFSAX Vanguard FTSE All-World ex-US Small-Cap Index Fund Admiral Shares 0 35.49
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0 45.18
VTIAX Vanguard Total International Stock Index Fd Admiral 0 39.5
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 48.55
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0 114.29
VTWIX Vanguard Total World Stock Index I 0 279.88
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 157.99
Unlock